ProMIS Neurosciences, Inc.
PMN
$0.5359
-$0.0131-2.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 8.75M | 5.46M | 4.32M | 2.56M | 1.63M |
| Gross Profit | -8.75M | -5.46M | -4.32M | -2.56M | -1.63M |
| SG&A Expenses | 1.43M | 2.00M | -1.82M | 1.87M | 1.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.18M | 7.46M | 2.50M | 4.43M | 2.71M |
| Operating Income | -10.18M | -7.46M | -2.50M | -4.43M | -2.71M |
| Income Before Tax | -10.12M | -7.35M | -238.20K | 9.28M | -2.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.12M | -7.35M | -238.20K | 9.28M | -2.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.12M | -7.35M | -238.20K | 9.28M | -2.62M |
| EBIT | -10.18M | -7.46M | -2.50M | -4.43M | -2.71M |
| EBITDA | -- | -- | -2.50M | -4.43M | -2.71M |
| EPS Basic | -0.29 | -0.21 | -0.01 | 0.31 | -0.13 |
| Normalized Basic EPS | -0.18 | -0.13 | 0.06 | 0.19 | -0.08 |
| EPS Diluted | -0.29 | -0.21 | -0.01 | 0.31 | -0.13 |
| Normalized Diluted EPS | -0.18 | -0.13 | 0.06 | 0.19 | -0.08 |
| Average Basic Shares Outstanding | 34.85M | 34.85M | 34.82M | 30.02M | 19.77M |
| Average Diluted Shares Outstanding | 34.85M | 34.85M | 34.82M | 30.07M | 19.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |